FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Jurcic

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Objects

Alpha Particles

Co-author Network

Publications

TOP 3
Renier J Brentjens; Lindsay G Cowell; Kevin Curran; Marco L Davila; Mark Frattini; Qing He; Cyrus Hedvat; Joseph G Jurcic; Rachel Kobos; Peter Maslak; Malgorzata Olszewska; Jae Park; Jinrong Qu; Ivelise V Rijo; Isabelle Riviere; Todd Rosenblat; Jolanta Stefanski; Peter Steinherz; Clare Taylor; Xiuyan Wang; Teresa Wasielewska; Shirley Bartido; Yvette Bernal; Oriana Borquez-Ojeda; Michel Sadelain
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.
Jenna D Goldberg; Glenn Heller; Katharine Hsu; Ann A Jakubowski; Robert Jenq; Joseph G Jurcic; Nancy A Kernan; Guenther Koehne; Deborah Kuk; Alex Linker; Richard J O'Reilly; Esperanza B Papadopoulos; Juliet N Barker; Farid Boulad; Hugo Castro-Malaspina; Sergio Giralt; Susan E Prockop; Ravin Ratan; Marcel R M van den Brink; Joachim Yahalom; James W Young; Miguel-Angel Perales
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.
Adi Diab; Dan Douer; Hugo F Fernandez; Manjit A Gulam; Suresh Jhanwar; Joseph G Jurcic; Hillard M Lazarus; Ross L Levine; Mark R Litzow; Selina M Luger; James K Mangan; Peter Maslak; Elisabeth Paietta; Katherine S Panageas; Jay P Patel; Jacob M Rowe; Omar Abdel-Wahab; Martin Carroll; Julie Teruya-Feldstein; Lynette Zickl; Martin S Tallman
Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Jurcic (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Renier J Brentjens; Lindsay G Cowell; Kevin Curran; Marco L Davila; Mark Frattini; Qing He; Cyrus Hedvat; Joseph G Jurcic; Rachel Kobos; Peter Maslak; Malgorzata Olszewska; Jae Park; Jinrong Qu; Ivelise V Rijo; Isabelle Riviere; Todd Rosenblat; Jolanta Stefanski; Peter Steinherz; Clare Taylor; Xiuyan Wang; Teresa Wasielewska; Shirley Bartido; Yvette Bernal; Oriana Borquez-Ojeda; Michel Sadelain
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.
Science translational medicine 2013;5(177):177ra38.
2013: Jenna D Goldberg; Glenn Heller; Katharine Hsu; Ann A Jakubowski; Robert Jenq; Joseph G Jurcic; Nancy A Kernan; Guenther Koehne; Deborah Kuk; Alex Linker; Richard J O'Reilly; Esperanza B Papadopoulos; Juliet N Barker; Farid Boulad; Hugo Castro-Malaspina; Sergio Giralt; Susan E Prockop; Ravin Ratan; Marcel R M van den Brink; Joachim Yahalom; James W Young; Miguel-Angel Perales
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):208-13.
2013: Adi Diab; Dan Douer; Hugo F Fernandez; Manjit A Gulam; Suresh Jhanwar; Joseph G Jurcic; Hillard M Lazarus; Ross L Levine; Mark R Litzow; Selina M Luger; James K Mangan; Peter Maslak; Elisabeth Paietta; Katherine S Panageas; Jay P Patel; Jacob M Rowe; Omar Abdel-Wahab; Martin Carroll; Julie Teruya-Feldstein; Lynette Zickl; Martin S Tallman
Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis.
Leukemia research 2013;37(1):32-6.
2013: Mikkael A Sekeres; Eric L Sievers; Brent L Wood; Laurie E Grove; Jeffrey E Lancet; Larissa Sandalic; Joseph G Jurcic
Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia.
Haematologica 2013;98(1):119-28.
2012: Joseph G Jurcic
What happened to anti-CD33 therapy for acute myeloid leukemia?
Current hematologic malignancy reports 2012;7(1):65-73.
2011: Todd L Rosenblat; Joseph G Jurcic
Induction and postremission strategies in acute myeloid leukemia: state of the art and future directions.
Hematology/oncology clinics of North America 2011;25(6):1189-213.
2011: Renier J Brentjens; Marco L Davila; Mark Frattini; Elizabeth Halton; Mark L Heaney; Glenn Heller; Daniel Hollyman; James Hosey; Joseph G Jurcic; Peter Maslak; Malgorzata Olszewska; Jae H Park; Hollie Pegram; Domenick Pirraglia; Mark Przybylowski; Isabelle Riviere; Elmer Santos; David Scheinberg; Jolanta Stefanski; Clare Taylor; Yelena Usachenko; Xiuyan Wang; Raymond Yeh; Shirley Bartido; Yvette Bernal; Oriana Borquez-Ojeda; Michel Sadelain
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.
Blood 2011;118(18):4817-28.
2011: Jae Park; Todd Rosenblat; Joseph G Jurcic; Martin S Tallman
Emerging new approaches for the treatment of acute promyelocytic leukemia.
Therapeutic advances in hematology 2011;2(5):335-52.
2011: Jae H Park; Baozhen Qiao; Todd L Rosenblat; Jacob M Rowe; Maria J Schymura; Jessica K Altman; Dan Douer; Joseph G Jurcic; Katherine S Panageas; Martin S Tallman
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.
Blood 2011;118(5):1248-54.
2010: Todd Rosenblat; Michael R McDevitt; Deborah A Mulford; Neeta Pandit-Taskar; Chaitanya R Divgi; Katherine S Panageas; Mark L Heaney; Suzanne Chanel; Alfred Morgenstern; George Sgouros; Steven M Larson; David A Scheinberg; Joseph G Jurcic
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(21):5303-11.
2010: Peter Maslak; Tao Dao; Lee M Krug; Suzanne Chanel; Tatyana Korontsvit; Victoria Zakhaleva; Ronghua Zhang; Jedd D Wolchok; Jianda Yuan; Javier Pinilla-Ibarz; Ellin Berman; Mark Weiss; Joseph G Jurcic; Mark Frattini; David A Scheinberg
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.
Blood 2010;116(2):171-9.
2009: Stephen Harnicar; Nelly Adel; Joseph G Jurcic
Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2009;15(3):175-82.
2009: Azra Raza; Joseph G Jurcic; Gail J Roboz; Michael Maris; Joseph J Stephenson; Brent L Wood; Eric J Feldman; Naomi Galili; Laurie E Grove; Jonathan G Drachman; Eric L Sievers
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial.
Leukemia & lymphoma 2009;50(8):1336-44.
2009: Nicole Lamanna; Joseph G Jurcic; Ariela Noy; Peter Maslak; Alison Gencarelli; Katherine S Panageas; Mark L Heaney; Renier J Brentjens; David W Golde; David A Scheinberg; Andrew D Zelenetz; Mark A Weiss
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):491-7.
2007: Joseph G Jurcic; Steven L Soignet; And Peter G Maslak
Diagnosis and treatment of acute promyelocytic leukemia.
Current oncology reports 2007;9(5):337-44.
2007: Peter Maslak; Joseph G Jurcic; David A Scheinberg
Monoclonal antibody therapy of APL.
Current topics in microbiology and immunology 2007;313():205-19.
2006: David A Scheinberg; Joseph G Jurcic; Peter Maslak
Antibody-drug conjugates in acute myeloid leukemia.
Nature clinical practice. Oncology 2006;3(5):238-9.
2006: Nicole Lamanna; Matt Kalaycio; Peter Maslak; Joseph G Jurcic; Mark L Heaney; Renier J Brentjens; Andrew D Zelenetz; Denise Horgan; Alison Gencarelli; Katherine S Panageas; David A Scheinberg; Mark A Weiss
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1575-81.
2005: Joseph G Jurcic
Immunotherapy for acute myeloid leukemia.
Current oncology reports 2005;7(5):339-46.
2005: Eric J Feldman; Joseph Brandwein; Richard Stone; Matt Kalaycio; Joseph Moore; Julie O'Connor; Nancy Wedel; Gail J Roboz; Carole B Miller; rajesh Chopra; Joseph G Jurcic; Randy Brown; W Christopher Ehmann; Philip Schulman; Stanley R Frankel; Daniel De Angelo; David A Scheinberg
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4110-6.
2005: Deborah A Mulford; David A Scheinberg; Joseph G Jurcic
The promise of targeted {alpha}-particle therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():199S-204S.
2004: John M Burke; Joseph G Jurcic
Radioimmunotherapy of leukemia.
Advances in pharmacology (San Diego, Calif.) 2004;51():185-208.
2004: Deborah A Mulford; Joseph G Jurcic
Antibody-based treatment of acute myeloid leukaemia.
Expert opinion on biological therapy 2004;4(1):95-105.
2003: John M Burke; PC Caron; Esperanza B Papadopoulos; Chaitanya R Divgi; George Sgouros; Katherine S Panageas; Ronald D Finn; Steven M Larson; Richard J O'Reilly; David A Scheinberg; Joseph G Jurcic
Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias.
Bone marrow transplantation 2003;32(6):549-56.
2003: Joseph G Jurcic
Monitoring PML-RARalpha in acute promyelocytic leukemia.
Current oncology reports 2003;5(5):391-8.
2003: Mark A Weiss; Peter Maslak; Joseph G Jurcic; David A Scheinberg; Timothy B Aliff; Nicole Lamanna; Stanley R Frankel; Steven E Kossman; Denise Horgan
Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1278-84.
2003: Timothy B Aliff; Peter Maslak; Joseph G Jurcic; Mark L Heaney; Kathleen N Cathcart; Kent A Sepkowitz; Mark A Weiss
Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
Cancer 2003;97(4):1025-32.
2003: E Feldman; Matt Kalaycio; G Weiner; S Frankel; Philip Schulman; L Schwartzberg; Joseph G Jurcic; E Velez-Garcia; Karen Seiter; David A Scheinberg; D Levitt; N Wedel
Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195.
Leukemia 2003;17(2):314-8.
2002: Joseph G Jurcic; Steven M Larson; George Sgouros; Michael R McDevitt; Ronald D Finn; Chaitanya R Divgi; Ase M Ballangrud; Klaus A Hamacher; Dangshe Ma; John L Humm; Martin W Brechbiel; Roger Molinet; David A Scheinberg
Targeted alpha particle immunotherapy for myeloid leukemia.
Blood 2002;100(4):1233-9.
2002: Mark A Weiss; Timothy B Aliff; Martin S Tallman; Stanley R Frankel; Matt Kalaycio; Peter Maslak; Joseph G Jurcic; David A Scheinberg; Todd E Roma
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia.
Cancer 2002;95(3):581-7.
2002: Peter B Bach; Sharp F Malak; Joseph G Jurcic; Sarah E Gelfand; Janet Eagan; Claudia Little; Kent A Sepkowitz
Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2002;23(8):471-4.
2002: John M Burke; Joseph G Jurcic
Antibody therapy in acute myeloid leukemia: current status and future directions.
Clinical lymphoma 2002;2 Suppl 1():S12-8.
2002: John M Burke; Joseph G Jurcic; David A Scheinberg
Radioimmunotherapy for acute leukemia.
Cancer control : journal of the Moffitt Cancer Center 2002;9(2):106-13.
2001: Joseph G Jurcic; Stephen D Nimer; David A Scheinberg; Tony DeBlasio; RP Warrell; W H Miller
Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia.
Blood 2001;98(9):2651-6.
2001: Eunice S Wang; Peter Maslak; Kathleen N Cathcart; Joseph G Jurcic
Acute myeloid leukemia with t(5;18)(q35;q21).
Cancer genetics and cytogenetics 2001;127(1):71-3.
2001: Joseph G Jurcic
Antibody therapy for residual disease in acute myelogenous leukemia.
Critical reviews in oncology/hematology 2001;38(1):37-45.
2001: A E Frankel; Michael W Schuster; Joseph G Jurcic
Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2001;15(1):55-71.
2001: Katherine S Kolbert; Klaus A Hamacher; Joseph G Jurcic; David A Scheinberg; Steven M Larson; George Sgouros
Parametric images of antibody pharmacokinetics in Bi213-HuM195 therapy of leukemia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(1):27-32.
2000: Joseph G Jurcic
Antibody therapy of acute myelogenous leukemia.
Cancer biotherapy & radiopharmaceuticals 2000;15(4):319-26.
2000: Joseph G Jurcic; Kathleen N Cathcart; Javier Pinilla-Ibarz; David A Scheinberg
Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches.
Current opinion in hematology 2000;7(4):247-54.
2000: Joseph G Jurcic
Antibody immunotherapy for leukemia.
Current oncology reports 2000;2(2):114-22.
2000: Joseph G Jurcic; Tony DeBlasio; L Dumont; Tzy-Jyun Yao; David A Scheinberg
Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):372-80.
1999: Craig Moskowitz; Joseph R Bertino; Jill Glassman; Eric Hedrick; S Hunte; N Coady-Lyons; David B Agus; Andre Goy; Joseph G Jurcic; Ariela Noy; J O'Brien; Carol S Portlock; D S Straus; Barrett H Childs; R Frank; Joachim Yahalom; Daniel A Filippa; Diane C Louie; Stephen D Nimer; Andrew D Zelenetz
Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3776-85.
1999: George Sgouros; Ase M Ballangrud; Joseph G Jurcic; Michael R McDevitt; John L Humm; Yusuf E Erdi; Bipin M Mehta; Ronald D Finn; Steven M Larson; David A Scheinberg
Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(11):1935-46.
1999: Joseph G Jurcic; David A Scheinberg
Radionuclides as conditioning before stem cell transplantation.
Current opinion in hematology 1999;6(6):371-6.
1999: Steven E Kossman; David A Scheinberg; Joseph G Jurcic; J Jimenez; PC Caron
A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2748-55.
1998: Michael R McDevitt; George Sgouros; Ronald D Finn; John L Humm; Joseph G Jurcic; Steven M Larson; David A Scheinberg
Radioimmunotherapy with alpha-emitting nuclides.
European journal of nuclear medicine 1998;25(9):1341-51.
1997: Joseph G Jurcic; David A Scheinberg; Alan N Houghton
Monoclonal antibody therapy of cancer.
Cancer chemotherapy and biological response modifiers 1997;17():195-216.
1996: Joseph G Jurcic; David A Scheinberg; Alan N Houghton
Monoclonal antibody therapy of cancer.
Cancer chemotherapy and biological response modifiers 1996;16():168-88.
1995: Joseph G Jurcic; David A Scheinberg
Radioimmunotherapy of hematological cancer: problems and progress.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(12):1439-46.
1995: Joseph G Jurcic; P C Caron; T K Nikula; Esperanza B Papadopoulos; Ronald D Finn; Otto A Gansow; W H Miller; M W Geerlings; RP Warrell; Steven M Larson
Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias.
Cancer research 1995;55(23 Suppl):5908s-5910s.
1995: Joseph G Jurcic; P C Caron; W H Miller; Tzy-Jyun Yao; Peter Maslak; Ronald D Finn; Steven M Larson; RP Warrell; David A Scheinberg
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
Leukemia 1995;9(2):244-8.
1995: Joseph G Jurcic; P C Caron; David A Scheinberg
Monoclonal antibody therapy of leukemia and lymphoma.
Advances in pharmacology (San Diego, Calif.) 1995;33():287-314.
1994: Joseph G Jurcic; David A Scheinberg
Recent developments in the radioimmunotherapy of cancer.
Current opinion in immunology 1994;6(5):715-21.
1994: P C Caron; Joseph G Jurcic; A M Scott; Ronald D Finn; Chaitanya R Divgi; MC Graham; I M Jureidini; George Sgouros; D Tyson; Lloyd J Old
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity.
Blood 1994;83(7):1760-8.
1994: Joseph G Jurcic; Brian Koll; Arthur E Brown; John Crown; Joachim Yahalom; S C Gulati
Excretion of Ascaris lumbricoides during total body irradiation.
Bone marrow transplantation 1994;13(4):491-3.
1994: Joseph G Jurcic; David A Scheinberg; Alan N Houghton
Monoclonal antibody therapy of cancer.
Cancer chemotherapy and biological response modifiers 1994;15():152-75.
1993: Joseph G Jurcic; David A Scheinberg; Alan N Houghton
Monoclonal antibody therapy of cancer.
Cancer chemotherapy and biological response modifiers 1993;14():129-49.